Literature DB >> 29144466

Influenza: A broadly protective antibody.

Peter Palese1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 29144466     DOI： 10.1038/551310a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Highly conserved protective epitopes on influenza B viruses.

Authors:  Cyrille Dreyfus; Nick S Laursen; Ted Kwaks; David Zuijdgeest; Reza Khayat; Damian C Ekiert; Jeong Hyun Lee; Zoltan Metlagel; Miriam V Bujny; Mandy Jongeneelen; Remko van der Vlugt; Mohammed Lamrani; Hans J W M Korse; Eric Geelen; Özcan Sahin; Martijn Sieuwerts; Just P J Brakenhoff; Ronald Vogels; Olive T W Li; Leo L M Poon; Malik Peiris; Wouter Koudstaal; Andrew B Ward; Ian A Wilson; Jaap Goudsmit; Robert H E Friesen
Journal:  Science       Date:  2012-08-09       Impact factor: 47.728

2.  Optimal activation of Fc-mediated effector functions by influenza virus hemagglutinin antibodies requires two points of contact.

Authors:  Paul E Leon; Wenqian He; Caitlin E Mullarkey; Mark J Bailey; Matthew S Miller; Florian Krammer; Peter Palese; Gene S Tan
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-19       Impact factor: 11.205

3.  HA Antibody-Mediated FcγRIIIa Activity Is Both Dependent on FcR Engagement and Interactions between HA and Sialic Acids.

Authors:  Freek Cox; Ted Kwaks; Boerries Brandenburg; Martin H Koldijk; Vincent Klaren; Bastiaan Smal; Hans J W M Korse; Eric Geelen; Lisanne Tettero; David Zuijdgeest; Esther J M Stoop; Eirikur Saeland; Ronald Vogels; Robert H E Friesen; Wouter Koudstaal; Jaap Goudsmit
Journal:  Front Immunol       Date:  2016-09-29       Impact factor: 7.561

4.  A broadly protective therapeutic antibody against influenza B virus with two mechanisms of action.

Authors:  Ning Chai; Lee R Swem; Summer Park; Gerald Nakamura; Nancy Chiang; Alberto Estevez; Rina Fong; Lynn Kamen; Elviza Kho; Mike Reichelt; Zhonghua Lin; Henry Chiu; Elizabeth Skippington; Zora Modrusan; Jeremy Stinson; Min Xu; Patrick Lupardus; Claudio Ciferri; Man-Wah Tan
Journal:  Nat Commun       Date:  2017-01-19       Impact factor: 14.919

5.  Human monoclonal antibodies broadly neutralizing against influenza B virus.

Authors:  Mayo Yasugi; Ritsuko Kubota-Koketsu; Akifumi Yamashita; Norihito Kawashita; Anariwa Du; Tadahiro Sasaki; Mitsuhiro Nishimura; Ryo Misaki; Motoki Kuhara; Naphatsawan Boonsathorn; Kazuhito Fujiyama; Yoshinobu Okuno; Takaaki Nakaya; Kazuyoshi Ikuta
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.